On September 8, 2020 Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, reported that its management is scheduled to present at the H.C. Wainwright 22nd Annual Global Investment Conference to be held virtually on September 14-16, 2020 (Press release, Citius Pharmaceuticals, SEP 8, 2020, https://www.prnewswire.com/news-releases/citius-pharmaceuticals-to-present-at-hc-wainwright-virtual-22nd-annual-global-investment-conference-301124698.html [SID1234564782]). Leonard Mazur, Chairman of Citius, will present on Tuesday, September 15, at 11:00 a.m. Eastern Time where he will deliver a corporate overview of the Company.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
In addition he will be providing updates that include the recent expansion of the Company’s intellectual property for Mino-Wrap, a novel approach to reducing post-operative infections associated with surgical implants, future plans to potentially treat and reduce the severity of acute respiratory distress syndrome (ARDS) associated with COVID-19, and Mino-Lok, an antibiotic lock treatment for catheter-related bloodstream infections (CRBSIs), in collaboration with MDACC.
Webcast: View Source
Mr. Mazur will conduct virtual one-on-one meetings with investors during the conference.